Join Dr. Mariah Pierce, Technical Account Manager at Sino Biological, as she introduces Sino Biological's cutting-edge, high-throughput, cell-free expression platform. This platform facilitates the ...

As artificial intelligence and machine learning increasingly shape the design and optimization of therapeutic protein candidates, researchers require expression ...

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...

Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis.

Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for expanded multiplexing Enables up to 24 targets per sample and supports ...

Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...

This article highlights the use of SCIEX ZenoTOF 8600 equipment for high-throughput quantitative proteomics analysis. Using improved separations with the Evosep One system and high-sensitivity ...

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...